Crescent Biopharma Ord Shs
CBIO14.490USD
+0.520+3.72%
Close 12/10, 16:00（ET）Quotes delayed by 15 min
201.30MMarket Cap
LossP/E TTM
Crescent Biopharma Ord Shs Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-58.75
--
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its Earnings Per Share (EPS) was -58.748, with a year-on-year change of --.
What is the net income of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its net income was -37.88M, with a year-on-year change of --.
What is the net margin of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its Return on Equity (ROE) was -173.25%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its Return on Assets (ROA) was -134.30%, with a year-on-year change of --.
What is the operating profit of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its operating profit was -32.51M, with a year-on-year change of --.
What are the current assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its current assets were 11.09M, with a year-on-year change of --.
What are the total assets of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its total assets of Crescent Biopharma Ord Shs were 11.09M, with a year-on-year change of --.
What are the total liabilities of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its total liabilities of Crescent Biopharma Ord Shs were 5.78M, with a year-on-year change of --.
What is the total equity of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its total equity of Crescent Biopharma Ord Shs was 5.31M, with a year-on-year change of --.
What is the net operating income of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its net operating income of Crescent Biopharma Ord Shs was -37.88M, with a year-on-year change of --.
What is the net investment of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its net investment of Crescent Biopharma Ord Shs was 20.03K, with a year-on-year change of --.
What is the net financing of Crescent Biopharma Ord Shs?
According to Crescent Biopharma Ord Shs's FY2024 earnings report, its net financing of Crescent Biopharma Ord Shs was 5.40K, with a year-on-year change of --.
